Agreed, no dead anything here!

but what is highly suggestive, based on trading trend upto the topline release & then since that day, is that the so called “someone knows something” is working behind the scenes here!

We will be moving higher and higher from this point.

just wondering how the company is going to orchestrate the release of data for renal and cognition subtrial to optimize SP appreciation!